Harry L. Gewanter

2.4k total citations
19 papers, 487 citations indexed

About

Harry L. Gewanter is a scholar working on Epidemiology, Rheumatology and Hematology. According to data from OpenAlex, Harry L. Gewanter has authored 19 papers receiving a total of 487 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Epidemiology, 6 papers in Rheumatology and 5 papers in Hematology. Recurrent topics in Harry L. Gewanter's work include Autoimmune and Inflammatory Disorders Research (5 papers), Inflammatory Myopathies and Dermatomyositis (4 papers) and Neurogenetic and Muscular Disorders Research (3 papers). Harry L. Gewanter is often cited by papers focused on Autoimmune and Inflammatory Disorders Research (5 papers), Inflammatory Myopathies and Dermatomyositis (4 papers) and Neurogenetic and Muscular Disorders Research (3 papers). Harry L. Gewanter collaborates with scholars based in United States and Canada. Harry L. Gewanter's co-authors include John Baum, Frank M. Biro, Klaus J. Roghmann, Lauren M. Pachman, Alan R. Dyer, Marc C. Hochberg, Jennifer R. Hayford, Rita Jerath, Ilona S. Szer and Mark A. Pallansch and has published in prestigious journals such as Journal of Clinical Oncology, PEDIATRICS and Annals of the Rheumatic Diseases.

In The Last Decade

Harry L. Gewanter

19 papers receiving 450 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Harry L. Gewanter United States	8	191	165	138	115	86	19	487
N. Adib United Kingdom	6	35 0.2×	86 0.5×	170 1.2×	178 1.5×	141 1.6×	8	436
Gian Michele Magnano Italy	11	111 0.6×	117 0.7×	18 0.1×	109 0.9×	105 1.2×	34	351
Susan Nielsen Denmark	16	107 0.6×	301 1.8×	33 0.2×	104 0.9×	523 6.1×	43	769
Prasad T. Oommen Germany	13	92 0.5×	77 0.5×	20 0.1×	48 0.4×	139 1.6×	44	391
Kristen Hayward United States	10	29 0.2×	96 0.6×	25 0.2×	66 0.6×	210 2.4×	18	413
Béatrice Dott France	18	128 0.7×	66 0.4×	311 2.3×	418 3.6×	11 0.1×	28	964
Maher Ben Ghachem Tunisia	13	49 0.3×	80 0.5×	112 0.8×	204 1.8×	19 0.2×	67	443
Karima Benbouazza Morocco	11	23 0.1×	197 1.2×	20 0.1×	118 1.0×	82 1.0×	37	382
Peter J. Koblenzer United States	14	38 0.2×	84 0.5×	69 0.5×	117 1.0×	29 0.3×	31	507
E. H. Pieter van Dijkhuizen Netherlands	11	26 0.1×	128 0.8×	27 0.2×	92 0.8×	421 4.9×	16	570

Countries citing papers authored by Harry L. Gewanter

Since Specialization

Citations

This map shows the geographic impact of Harry L. Gewanter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Harry L. Gewanter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Harry L. Gewanter more than expected).

Fields of papers citing papers by Harry L. Gewanter

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Harry L. Gewanter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Harry L. Gewanter. The network helps show where Harry L. Gewanter may publish in the future.

Co-authorship network of co-authors of Harry L. Gewanter

This figure shows the co-authorship network connecting the top 25 collaborators of Harry L. Gewanter. A scholar is included among the top collaborators of Harry L. Gewanter based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Harry L. Gewanter. Harry L. Gewanter is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

Kim, Hanna, Amanda Brown, Harry L. Gewanter, et al.. (2023). Treatment escalation patterns to start biologics in refractory moderate juvenile dermatomyositis among members of the Childhood Arthritis and Rheumatology Research Alliance. Pediatric Rheumatology. 21(1). 3–3. 4 indexed citations

Gewanter, Harry L., et al.. (2020). Multi-pronged approach to enhance education of children and adolescents with lupus, caregivers, and healthcare providers in New Jersey: Needs assessment, evaluation, and development of educational materials. Lupus. 30(1). 86–95. 3 indexed citations

Gewanter, Harry L., et al.. (2017). Naming and labelling of biologicals – a survey of US physicians’ perspectives. Generics and Biosimilars Initiative Journal. 6(1). 7–12. 1 indexed citations

Molinari, Anna Lia, et al.. (2016). SAT0570 Biologics and Biosimilars: Do Physicians Understand The Differences?. Annals of the Rheumatic Diseases. 75. 875–876. 1 indexed citations

Molinari, Anna Lia, et al.. (2016). Global survey of physicians’ attitudes toward biologic and biosimilar therapies.. Journal of Clinical Oncology. 34(15_suppl). e18025–e18025. 1 indexed citations

Gewanter, Harry L., et al.. (2015). Prescribing practices for biosimilars: questionnaire survey findings from physicians in Argentina, Brazil, Colombia and Mexico. Generics and Biosimilars Initiative Journal. 4(4). 161–166. 10 indexed citations

Pachman, Lauren M., Jennifer R. Hayford, Mark A. Pallansch, et al.. (1998). Juvenile dermatomyositis at diagnosis: clinical characteristics of 79 children.. PubMed. 25(6). 1198–204. 131 indexed citations

Pachman, Lauren M., Jennifer R. Hayford, Marc C. Hochberg, et al.. (1997). New‐onset juvenile dermatomyositis. Comparisons with a healthy cohort and children with juvenile rheumatoid arthritis. Arthritis & Rheumatism. 40(8). 1526–1533. 38 indexed citations

Pachman, Lauren M., Jennifer R. Hayford, Mark A. Pallansch, et al.. (1997). Juvenile Dermatomyositis at Onset: Demographics, Clinical Characteristics, and Access to Care. ♦ 1844. Pediatric Research. 41. 310–310. 1 indexed citations

10.

Perrin, J, Gerald Erenberg, John A. Nackashi, et al.. (1997). The role of the pediatrician in prescribing therapy services for children with motor disabilities. 9(2). 78–80. 1 indexed citations

11.

Newcomb, Andrew F., et al.. (1991). Psychosocial effects of juvenile rheumatic disease the family and peer systems as a context for coping. Arthritis & Rheumatism. 4(3). 123–130. 27 indexed citations

12.

Gedalia, Abraham, Harry L. Gewanter, & John Baum. (1989). Dark skin discoloration of finger joints in juvenile arthritis.. PubMed. 16(6). 797–9. 3 indexed citations

13.

Gewanter, Harry L. & J D Baum. (1985). Thiemann's disease.. PubMed. 12(1). 150–3. 3 indexed citations

14.

Kreipe, Richard E. & Harry L. Gewanter. (1985). Physical Maturity Screening for Participation in Sports. PEDIATRICS. 75(6). 1076–1080. 20 indexed citations

15.

Gewanter, Harry L., et al.. (1984). THE HYPERMOBILITY SYNDROME. Journal of Pediatric Orthopaedics. 4(2). 265–265. 8 indexed citations

16.

Biro, Frank M., Harry L. Gewanter, & John Baum. (1983). The Hypermobility Syndrome. PEDIATRICS. 72(5). 701–706. 167 indexed citations

17.

Gewanter, Harry L., Klaus J. Roghmann, & John Baum. (1983). The Prevalence of Juvenile Arthritis. Arthritis & Rheumatism. 26(5). 599–603. 61 indexed citations

18.

Gewanter, Harry L. & John Baum. (1981). The use of tolmetin sodium in systemic onset juvenile rheumatoid arthritis. Arthritis & Rheumatism. 24(10). 1316–1319. 6 indexed citations

19.

Adair, Steven M., et al.. (1981). Temporomandibular joint involvement in juvenile rheumatoid arthritis: report of two cases.. PubMed. 3(3). 271–3. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact